FNY Among Mid Cap ETFs
End-of-day Nov 18, 2026 · 93 Mid cap ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.7% | −4.3% | −2.8% | −8.7% | +4.4% | +9.9% | +63.5% | +23.8% | +232.1% | +382.3% |
| Peer average | +0.3% | −3.6% | −1.7% | −4.9% | +9.9% | +15.8% | +56.9% | +35.7% | +187.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$11 of every $1,000 in FNY is Glaukos
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GKOSGlaukos | Healthcare | 1.14% | $114.40 | 25K | $6.1M |
| 2 | CHYMChime Financial, () | Technology | 0.96% | $95.56 | 153K | $5.1M |
| 3 | CONConcentra Group Parent | Healthcare | 0.95% | $95.07 | 119K | $5.0M |
| 4 | LFSTLifeStance Health Group | Healthcare | 0.91% | $90.95 | 340K | $4.8M |
| 5 | HNGEHinge Health, () | Healthcare | 0.91% | $90.85 | 42K | $4.8M |
| 6 | EXELExelixis | Healthcare | 0.91% | $90.55 | 70K | $4.8M |
| 7 | PACSPACS Group | Healthcare | 0.90% | $90.22 | 98K | $4.8M |
| 8 | HAEHaemonetics | Healthcare | 0.89% | $88.67 | 39K | $4.7M |
| 9 | CRLCharles River Laboratories International | Healthcare | 0.87% | $86.93 | 14K | $4.6M |
| 10 | TGTXTG Therapeutics | Healthcare | 0.87% | $86.81 | 73K | $4.6M |
| 11 | XMTRXometry, () | Industrials | 0.86% | $86.30 | 40K | $4.6M |
| 12 | VSXYVictoria's Secret | Consumer Cyclical | 0.86% | $86.15 | 46K | $4.6M |
| 13 | COKECoca-Cola Consolidated | Consumer Defensive | 0.84% | $83.95 | 22K | $4.4M |
| 14 | CARTMaplebear (Instacart) | Technology | 0.84% | $83.83 | 76K | $4.4M |
| 15 | VCTRVictory Capital () | Financial Services | 0.82% | $82.30 | 37K | $4.4M |
of the $520B in 108 Mid cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GKOS | Glaukos | 1.14% |
| 2 | CHYM | Chime Financial, () | 0.96% |
| 3 | CON | Concentra Group Parent | 0.95% |
| 4 | LFST | LifeStance Health Group | 0.91% |
| 5 | HNGE | Hinge Health, () | 0.91% |
| 6 | EXEL | Exelixis | 0.91% |
| 7 | PACS | PACS Group | 0.90% |
| 8 | HAE | Haemonetics | 0.89% |
| 9 | CRL | Charles River Laboratories International | 0.87% |
| 10 | TGTX | TG Therapeutics | 0.87% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 26, 2025 | Jun 30, 2025 | $0.0297 |
| Dec 13, 2024 | Dec 31, 2024 | $0.14 |
| Sep 26, 2024 | Sep 30, 2024 | $0.31 |
| Dec 22, 2023 | Dec 29, 2023 | $0.0619 |
| Jun 27, 2023 | Jun 30, 2023 | $0.0218 |
| Mar 24, 2023 | Mar 31, 2023 | $0.0830 |
| Dec 23, 2022 | Dec 30, 2022 | $0.11 |
| Sep 23, 2022 | Sep 30, 2022 | $0.0225 |
| Dec 24, 2020 | Dec 31, 2020 | $0.0697 |
| Sep 24, 2020 | Sep 30, 2020 | $0.0897 |
| Mar 26, 2020 | Mar 31, 2020 | $0.0040 |
| Dec 13, 2019 | Dec 31, 2019 | $0.11 |